A simple mathematical model for relapsing-remitting multiple sclerosis (RRMS)

被引：10
作者：
Elettreby, M. F. [1 ,2 ]
Ahmed, E. [2 ]
机构：
[1] King Khalid Univ, Fac Sci, Math Dept, Abha 9004, Saudi Arabia
[2] Mansoura Univ, Fac Sci, Math Dept, Mansoura 35516, Egypt
来源：
MEDICAL HYPOTHESES | 2020年 / 135卷
关键词：
Multiple sclerosis; Relapse; Recurrence; Autoimmune diseases; Complex system; MATTER VOLUME; LYMPHOCYTES; CYTOKINES; BRAIN; GREY;
D O I：
10.1016/j.mehy.2019.109478
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Multiple sclerosis is one of the most common autoimmune-related neurological disorders affecting the central nervous system. One of its main properties is dissemination of lesions in time and space. Here, we propose a simple mathematical model to describe the stages of disease progression with recurrence. We tried to find the steady states and evaluated their stability to identify the necessary conditions to produce the recurrence. Also, we described the analytical results with some numerical simulations.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [42] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [43] Peripheral oxidative stress in relapsing-remitting multiple sclerosis
    Tasset, Inmaculada
    Aguelera, Eduardo
    Sanchez-Lopez, Fernando
    Feijoo, Montserrat
    Giraldo, Ana I.
    Cruz, Antonio H.
    Gascon, Felix
    Tunez, Isaac
    CLINICAL BIOCHEMISTRY, 2012, 45 (06) : 440 - 444
  • [44] An investigation of auditory processing in relapsing-remitting multiple sclerosis
    Bissonnette, Jenna N. N.
    Pimer, Laura
    Francis, Ashley M. M.
    Hull, Krista M.
    Leckey, Jennifer
    MacGillivray, Megan
    Berrigan, Lindsay I. I.
    Fisher, Derek J. J.
    EXPERIMENTAL BRAIN RESEARCH, 2023, 241 (05) : 1319 - 1327
  • [45] Cognitive deficits in early relapsing-remitting multiple sclerosis
    Tinnefeld, M.
    Wilhelm, H.
    Daum, I.
    Faustmann, P. M.
    Haase, C. G.
    AKTUELLE NEUROLOGIE, 2008, 35 (01) : 2 - 7
  • [46] Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
    Papadopoulou, Athina
    Kappos, Ludwig
    Sprenger, Till
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 749 - 759
  • [47] Immunologic therapy for relapsing-remitting multiple sclerosis.
    MacLean H.J.
    Freedman M.S.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 277 - 285
  • [48] Prodrome in relapsing-remitting and primary progressive multiple sclerosis
    Wijnands, J. M. A.
    Zhu, F.
    Kingwell, E.
    Zhao, Y.
    Evans, C.
    Fisk, J. D.
    Marrie, R. A.
    Tremlett, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (07) : 1032 - 1036
  • [49] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [50] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis?
    不详
    Drugs & Therapy Perspectives, 1998, 11 (10) : 1 - 5
12345